Investigating the quantitative fidelity of prospectively undersampled chemical shift imaging in muscular dystrophy with compressed sensing and parallel imaging reconstruction

Abstract

Purpose: Fat fraction measurement in muscular dystrophy has an important role to play in future therapy trials. Undersampled data acquisition reconstructed by combined compressed sensing and parallel imaging (CS-PI) can potentially reduce trial cost and improve compliance. These benefits are only gained from prospectively undersampled acquisitions.

Methods: Eight patients with Becker muscular dystrophy were recruited and prospectively undersampled data at ratios of 3.65×, 4.94×, and 6.42× were acquired in addition to fully sampled data: equivalent coherent undersamplings were acquired for reconstruction with parallel imaging alone (PI). Fat fraction maps and maps of total signal were created using a combined compressed sensing/parallel imaging (CS-PI) reconstruction.

Results: The CS-PI reconstructions are of sufficient quality to allow muscle delineation at 3.65× and 4.94× undersampling but some muscles were obscured at 6.42×. When plotted against the fat fractions derived from fully sampled data, non-significant bias and 95% limits of agreement of 1.58%, 2.17% and 2.41% were found for the three CS-PI reconstructions, while a 3.36× PI reconstruction yields 2.78%, 1.8 times worse than the equivalent CS-PI reconstruction.

Conclusion: Prospective undersampling and CS-PI reconstruction of muscle fat fraction mapping can be used to accelerate muscle fat fraction measurement in muscular dystrophy.

Keywords: BMD; MRI; biomarker; compressed sensing; muscular dystrophy.